nodes	percent_of_prediction	percent_of_DWPC	metapath
Ceftriaxone—SLC22A11—Conjugated Estrogens—osteoporosis	0.164	0.227	CbGbCtD
Ceftriaxone—SLC22A11—Estradiol—osteoporosis	0.144	0.199	CbGbCtD
Ceftriaxone—ALB—Estropipate—osteoporosis	0.12	0.166	CbGbCtD
Ceftriaxone—SLC22A8—Conjugated Estrogens—osteoporosis	0.0955	0.132	CbGbCtD
Ceftriaxone—SLC22A8—Estradiol—osteoporosis	0.0838	0.116	CbGbCtD
Ceftriaxone—SLC22A6—Conjugated Estrogens—osteoporosis	0.0665	0.0919	CbGbCtD
Ceftriaxone—ALB—Estradiol—osteoporosis	0.0497	0.0687	CbGbCtD
Ceftriaxone—Hyperhidrosis—Raloxifene—osteoporosis	0.000465	0.00168	CcSEcCtD
Ceftriaxone—Hyperhidrosis—Ibandronate—osteoporosis	0.00046	0.00166	CcSEcCtD
Ceftriaxone—Nausea—Ergocalciferol—osteoporosis	0.000458	0.00166	CcSEcCtD
Ceftriaxone—Ill-defined disorder—Ethinyl Estradiol—osteoporosis	0.000457	0.00165	CcSEcCtD
Ceftriaxone—Urticaria—Etidronic acid—osteoporosis	0.000456	0.00165	CcSEcCtD
Ceftriaxone—Bronchospasm—Estradiol—osteoporosis	0.000454	0.00164	CcSEcCtD
Ceftriaxone—Abdominal pain—Etidronic acid—osteoporosis	0.000453	0.00164	CcSEcCtD
Ceftriaxone—Pancreatitis—Estradiol—osteoporosis	0.000452	0.00164	CcSEcCtD
Ceftriaxone—Sweating increased—Estradiol—osteoporosis	0.000449	0.00163	CcSEcCtD
Ceftriaxone—Dysgeusia—Pamidronate—osteoporosis	0.000447	0.00162	CcSEcCtD
Ceftriaxone—Paraesthesia—Estropipate—osteoporosis	0.000445	0.00161	CcSEcCtD
Ceftriaxone—Flushing—Zoledronate—osteoporosis	0.000445	0.00161	CcSEcCtD
Ceftriaxone—Malaise—Ethinyl Estradiol—osteoporosis	0.000444	0.00161	CcSEcCtD
Ceftriaxone—Anaemia—Risedronate—osteoporosis	0.000444	0.00161	CcSEcCtD
Ceftriaxone—Dyspepsia—Estropipate—osteoporosis	0.000437	0.00158	CcSEcCtD
Ceftriaxone—Erythema multiforme—Conjugated Estrogens—osteoporosis	0.000436	0.00158	CcSEcCtD
Ceftriaxone—Dyspepsia—Alendronate—osteoporosis	0.00043	0.00156	CcSEcCtD
Ceftriaxone—Chills—Zoledronate—osteoporosis	0.00043	0.00156	CcSEcCtD
Ceftriaxone—Paraesthesia—Ibandronate—osteoporosis	0.000427	0.00155	CcSEcCtD
Ceftriaxone—Pain—Estropipate—osteoporosis	0.000424	0.00154	CcSEcCtD
Ceftriaxone—Ill-defined disorder—Pamidronate—osteoporosis	0.000424	0.00153	CcSEcCtD
Ceftriaxone—Dyspepsia—Raloxifene—osteoporosis	0.000423	0.00153	CcSEcCtD
Ceftriaxone—Hypersensitivity—Etidronic acid—osteoporosis	0.000422	0.00153	CcSEcCtD
Ceftriaxone—Anaemia—Pamidronate—osteoporosis	0.000422	0.00153	CcSEcCtD
Ceftriaxone—Agitation—Pamidronate—osteoporosis	0.00042	0.00152	CcSEcCtD
Ceftriaxone—Dyspepsia—Ibandronate—osteoporosis	0.000419	0.00152	CcSEcCtD
Ceftriaxone—Pain—Alendronate—osteoporosis	0.000418	0.00151	CcSEcCtD
Ceftriaxone—Discomfort—Ethinyl Estradiol—osteoporosis	0.000414	0.0015	CcSEcCtD
Ceftriaxone—Malaise—Pamidronate—osteoporosis	0.000412	0.00149	CcSEcCtD
Ceftriaxone—Pain—Raloxifene—osteoporosis	0.000411	0.00149	CcSEcCtD
Ceftriaxone—Leukopenia—Pamidronate—osteoporosis	0.000409	0.00148	CcSEcCtD
Ceftriaxone—Dysgeusia—Zoledronate—osteoporosis	0.000408	0.00148	CcSEcCtD
Ceftriaxone—Pain—Ibandronate—osteoporosis	0.000407	0.00147	CcSEcCtD
Ceftriaxone—Pruritus—Etidronic acid—osteoporosis	0.000406	0.00147	CcSEcCtD
Ceftriaxone—Gastrointestinal pain—Estropipate—osteoporosis	0.000406	0.00147	CcSEcCtD
Ceftriaxone—Feeling abnormal—Alendronate—osteoporosis	0.000403	0.00146	CcSEcCtD
Ceftriaxone—Oedema—Ethinyl Estradiol—osteoporosis	0.000402	0.00146	CcSEcCtD
Ceftriaxone—Jaundice—Estradiol—osteoporosis	0.000401	0.00145	CcSEcCtD
Ceftriaxone—Gastrointestinal pain—Alendronate—osteoporosis	0.0004	0.00145	CcSEcCtD
Ceftriaxone—Infection—Ethinyl Estradiol—osteoporosis	0.000399	0.00145	CcSEcCtD
Ceftriaxone—Pain—Calcitriol—osteoporosis	0.000398	0.00144	CcSEcCtD
Ceftriaxone—Flatulence—Conjugated Estrogens—osteoporosis	0.000396	0.00143	CcSEcCtD
Ceftriaxone—Convulsion—Pamidronate—osteoporosis	0.000396	0.00143	CcSEcCtD
Ceftriaxone—Urticaria—Estropipate—osteoporosis	0.000394	0.00143	CcSEcCtD
Ceftriaxone—Dysgeusia—Conjugated Estrogens—osteoporosis	0.000393	0.00142	CcSEcCtD
Ceftriaxone—Gastrointestinal pain—Raloxifene—osteoporosis	0.000393	0.00142	CcSEcCtD
Ceftriaxone—Diarrhoea—Etidronic acid—osteoporosis	0.000392	0.00142	CcSEcCtD
Ceftriaxone—Haematuria—Estradiol—osteoporosis	0.000392	0.00142	CcSEcCtD
Ceftriaxone—Abdominal pain—Estropipate—osteoporosis	0.000392	0.00142	CcSEcCtD
Ceftriaxone—Body temperature increased—Estropipate—osteoporosis	0.000392	0.00142	CcSEcCtD
Ceftriaxone—Feeling abnormal—Ibandronate—osteoporosis	0.000392	0.00142	CcSEcCtD
Ceftriaxone—Infection—Risedronate—osteoporosis	0.000389	0.00141	CcSEcCtD
Ceftriaxone—Gastrointestinal pain—Ibandronate—osteoporosis	0.000389	0.00141	CcSEcCtD
Ceftriaxone—Urticaria—Alendronate—osteoporosis	0.000388	0.0014	CcSEcCtD
Ceftriaxone—Epistaxis—Estradiol—osteoporosis	0.000388	0.0014	CcSEcCtD
Ceftriaxone—Ill-defined disorder—Zoledronate—osteoporosis	0.000387	0.0014	CcSEcCtD
Ceftriaxone—Body temperature increased—Alendronate—osteoporosis	0.000386	0.0014	CcSEcCtD
Ceftriaxone—Abdominal pain—Alendronate—osteoporosis	0.000386	0.0014	CcSEcCtD
Ceftriaxone—Anaemia—Zoledronate—osteoporosis	0.000386	0.0014	CcSEcCtD
Ceftriaxone—Discomfort—Pamidronate—osteoporosis	0.000384	0.00139	CcSEcCtD
Ceftriaxone—Agitation—Zoledronate—osteoporosis	0.000383	0.00139	CcSEcCtD
Ceftriaxone—Gastrointestinal pain—Calcitriol—osteoporosis	0.000381	0.00138	CcSEcCtD
Ceftriaxone—Body temperature increased—Raloxifene—osteoporosis	0.00038	0.00137	CcSEcCtD
Ceftriaxone—Abdominal pain—Raloxifene—osteoporosis	0.00038	0.00137	CcSEcCtD
Ceftriaxone—Urticaria—Ibandronate—osteoporosis	0.000378	0.00137	CcSEcCtD
Ceftriaxone—Malaise—Zoledronate—osteoporosis	0.000376	0.00136	CcSEcCtD
Ceftriaxone—Abdominal pain—Ibandronate—osteoporosis	0.000376	0.00136	CcSEcCtD
Ceftriaxone—Body temperature increased—Ibandronate—osteoporosis	0.000376	0.00136	CcSEcCtD
Ceftriaxone—Leukopenia—Zoledronate—osteoporosis	0.000373	0.00135	CcSEcCtD
Ceftriaxone—Anaphylactic shock—Pamidronate—osteoporosis	0.000373	0.00135	CcSEcCtD
Ceftriaxone—Oedema—Pamidronate—osteoporosis	0.000373	0.00135	CcSEcCtD
Ceftriaxone—Haemoglobin—Estradiol—osteoporosis	0.000371	0.00134	CcSEcCtD
Ceftriaxone—Infection—Pamidronate—osteoporosis	0.00037	0.00134	CcSEcCtD
Ceftriaxone—Urticaria—Calcitriol—osteoporosis	0.00037	0.00134	CcSEcCtD
Ceftriaxone—Haemorrhage—Estradiol—osteoporosis	0.000369	0.00134	CcSEcCtD
Ceftriaxone—Palpitations—Zoledronate—osteoporosis	0.000369	0.00133	CcSEcCtD
Ceftriaxone—Abdominal pain—Calcitriol—osteoporosis	0.000368	0.00133	CcSEcCtD
Ceftriaxone—Body temperature increased—Calcitriol—osteoporosis	0.000368	0.00133	CcSEcCtD
Ceftriaxone—Hypersensitivity—Estropipate—osteoporosis	0.000365	0.00132	CcSEcCtD
Ceftriaxone—Thrombocytopenia—Pamidronate—osteoporosis	0.000365	0.00132	CcSEcCtD
Ceftriaxone—Vomiting—Etidronic acid—osteoporosis	0.000365	0.00132	CcSEcCtD
Ceftriaxone—Rash—Etidronic acid—osteoporosis	0.000362	0.00131	CcSEcCtD
Ceftriaxone—Convulsion—Zoledronate—osteoporosis	0.000361	0.00131	CcSEcCtD
Ceftriaxone—Dermatitis—Etidronic acid—osteoporosis	0.000361	0.00131	CcSEcCtD
Ceftriaxone—Hyperhidrosis—Pamidronate—osteoporosis	0.00036	0.0013	CcSEcCtD
Ceftriaxone—Hypersensitivity—Alendronate—osteoporosis	0.00036	0.0013	CcSEcCtD
Ceftriaxone—Headache—Etidronic acid—osteoporosis	0.000359	0.0013	CcSEcCtD
Ceftriaxone—Palpitations—Conjugated Estrogens—osteoporosis	0.000355	0.00128	CcSEcCtD
Ceftriaxone—Paraesthesia—Risedronate—osteoporosis	0.000352	0.00127	CcSEcCtD
Ceftriaxone—Pruritus—Estropipate—osteoporosis	0.000351	0.00127	CcSEcCtD
Ceftriaxone—Discomfort—Zoledronate—osteoporosis	0.000351	0.00127	CcSEcCtD
Ceftriaxone—Hypersensitivity—Ibandronate—osteoporosis	0.00035	0.00127	CcSEcCtD
Ceftriaxone—Erythema multiforme—Estradiol—osteoporosis	0.000349	0.00126	CcSEcCtD
Ceftriaxone—Convulsion—Conjugated Estrogens—osteoporosis	0.000348	0.00126	CcSEcCtD
Ceftriaxone—Pruritus—Alendronate—osteoporosis	0.000346	0.00125	CcSEcCtD
Ceftriaxone—Dyspepsia—Risedronate—osteoporosis	0.000345	0.00125	CcSEcCtD
Ceftriaxone—Hypersensitivity—Calcitriol—osteoporosis	0.000343	0.00124	CcSEcCtD
Ceftriaxone—Flushing—Estradiol—osteoporosis	0.000343	0.00124	CcSEcCtD
Ceftriaxone—Nausea—Etidronic acid—osteoporosis	0.000341	0.00123	CcSEcCtD
Ceftriaxone—Anaphylactic shock—Zoledronate—osteoporosis	0.00034	0.00123	CcSEcCtD
Ceftriaxone—Oedema—Zoledronate—osteoporosis	0.00034	0.00123	CcSEcCtD
Ceftriaxone—Diarrhoea—Estropipate—osteoporosis	0.000339	0.00123	CcSEcCtD
Ceftriaxone—Infection—Zoledronate—osteoporosis	0.000338	0.00122	CcSEcCtD
Ceftriaxone—Pruritus—Ibandronate—osteoporosis	0.000337	0.00122	CcSEcCtD
Ceftriaxone—Pain—Risedronate—osteoporosis	0.000335	0.00121	CcSEcCtD
Ceftriaxone—Paraesthesia—Pamidronate—osteoporosis	0.000335	0.00121	CcSEcCtD
Ceftriaxone—Diarrhoea—Alendronate—osteoporosis	0.000334	0.00121	CcSEcCtD
Ceftriaxone—Thrombocytopenia—Zoledronate—osteoporosis	0.000333	0.00121	CcSEcCtD
Ceftriaxone—Feeling abnormal—Ethinyl Estradiol—osteoporosis	0.000331	0.0012	CcSEcCtD
Ceftriaxone—Chills—Estradiol—osteoporosis	0.000331	0.0012	CcSEcCtD
Ceftriaxone—Pruritus—Calcitriol—osteoporosis	0.000329	0.00119	CcSEcCtD
Ceftriaxone—Hyperhidrosis—Zoledronate—osteoporosis	0.000329	0.00119	CcSEcCtD
Ceftriaxone—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.000329	0.00119	CcSEcCtD
Ceftriaxone—Diarrhoea—Raloxifene—osteoporosis	0.000329	0.00119	CcSEcCtD
Ceftriaxone—Dyspepsia—Pamidronate—osteoporosis	0.000328	0.00119	CcSEcCtD
Ceftriaxone—Dizziness—Estropipate—osteoporosis	0.000328	0.00119	CcSEcCtD
Ceftriaxone—Anaphylactic shock—Conjugated Estrogens—osteoporosis	0.000328	0.00119	CcSEcCtD
Ceftriaxone—Oedema—Conjugated Estrogens—osteoporosis	0.000328	0.00119	CcSEcCtD
Ceftriaxone—Infection—Conjugated Estrogens—osteoporosis	0.000326	0.00118	CcSEcCtD
Ceftriaxone—Diarrhoea—Ibandronate—osteoporosis	0.000325	0.00118	CcSEcCtD
Ceftriaxone—Dizziness—Alendronate—osteoporosis	0.000323	0.00117	CcSEcCtD
Ceftriaxone—Gastrointestinal pain—Risedronate—osteoporosis	0.000321	0.00116	CcSEcCtD
Ceftriaxone—Urticaria—Ethinyl Estradiol—osteoporosis	0.000319	0.00116	CcSEcCtD
Ceftriaxone—Pain—Pamidronate—osteoporosis	0.000319	0.00115	CcSEcCtD
Ceftriaxone—Diarrhoea—Calcitriol—osteoporosis	0.000319	0.00115	CcSEcCtD
Ceftriaxone—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.000318	0.00115	CcSEcCtD
Ceftriaxone—Body temperature increased—Ethinyl Estradiol—osteoporosis	0.000318	0.00115	CcSEcCtD
Ceftriaxone—Dizziness—Raloxifene—osteoporosis	0.000318	0.00115	CcSEcCtD
Ceftriaxone—Hyperhidrosis—Conjugated Estrogens—osteoporosis	0.000317	0.00115	CcSEcCtD
Ceftriaxone—Flatulence—Estradiol—osteoporosis	0.000317	0.00115	CcSEcCtD
Ceftriaxone—Vomiting—Estropipate—osteoporosis	0.000315	0.00114	CcSEcCtD
Ceftriaxone—Dysgeusia—Estradiol—osteoporosis	0.000315	0.00114	CcSEcCtD
Ceftriaxone—Dizziness—Ibandronate—osteoporosis	0.000315	0.00114	CcSEcCtD
Ceftriaxone—Rash—Estropipate—osteoporosis	0.000313	0.00113	CcSEcCtD
Ceftriaxone—Dermatitis—Estropipate—osteoporosis	0.000312	0.00113	CcSEcCtD
Ceftriaxone—Urticaria—Risedronate—osteoporosis	0.000311	0.00113	CcSEcCtD
Ceftriaxone—Headache—Estropipate—osteoporosis	0.000311	0.00112	CcSEcCtD
Ceftriaxone—Vomiting—Alendronate—osteoporosis	0.000311	0.00112	CcSEcCtD
Ceftriaxone—Abdominal pain—Risedronate—osteoporosis	0.00031	0.00112	CcSEcCtD
Ceftriaxone—Body temperature increased—Risedronate—osteoporosis	0.00031	0.00112	CcSEcCtD
Ceftriaxone—Rash—Alendronate—osteoporosis	0.000308	0.00111	CcSEcCtD
Ceftriaxone—Dermatitis—Alendronate—osteoporosis	0.000308	0.00111	CcSEcCtD
Ceftriaxone—Feeling abnormal—Pamidronate—osteoporosis	0.000307	0.00111	CcSEcCtD
Ceftriaxone—Headache—Alendronate—osteoporosis	0.000306	0.00111	CcSEcCtD
Ceftriaxone—Paraesthesia—Zoledronate—osteoporosis	0.000306	0.00111	CcSEcCtD
Ceftriaxone—Vomiting—Raloxifene—osteoporosis	0.000306	0.00111	CcSEcCtD
Ceftriaxone—Gastrointestinal pain—Pamidronate—osteoporosis	0.000305	0.0011	CcSEcCtD
Ceftriaxone—Rash—Raloxifene—osteoporosis	0.000303	0.0011	CcSEcCtD
Ceftriaxone—Dermatitis—Raloxifene—osteoporosis	0.000303	0.0011	CcSEcCtD
Ceftriaxone—Vomiting—Ibandronate—osteoporosis	0.000302	0.00109	CcSEcCtD
Ceftriaxone—Headache—Raloxifene—osteoporosis	0.000301	0.00109	CcSEcCtD
Ceftriaxone—Rash—Ibandronate—osteoporosis	0.0003	0.00109	CcSEcCtD
Ceftriaxone—Dermatitis—Ibandronate—osteoporosis	0.0003	0.00108	CcSEcCtD
Ceftriaxone—Dyspepsia—Zoledronate—osteoporosis	0.0003	0.00108	CcSEcCtD
Ceftriaxone—Ill-defined disorder—Estradiol—osteoporosis	0.000298	0.00108	CcSEcCtD
Ceftriaxone—Headache—Ibandronate—osteoporosis	0.000298	0.00108	CcSEcCtD
Ceftriaxone—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.000296	0.00107	CcSEcCtD
Ceftriaxone—Vomiting—Calcitriol—osteoporosis	0.000296	0.00107	CcSEcCtD
Ceftriaxone—Agitation—Estradiol—osteoporosis	0.000295	0.00107	CcSEcCtD
Ceftriaxone—Nausea—Estropipate—osteoporosis	0.000295	0.00107	CcSEcCtD
Ceftriaxone—Abdominal pain—Pamidronate—osteoporosis	0.000295	0.00107	CcSEcCtD
Ceftriaxone—Body temperature increased—Pamidronate—osteoporosis	0.000295	0.00107	CcSEcCtD
Ceftriaxone—Paraesthesia—Conjugated Estrogens—osteoporosis	0.000294	0.00107	CcSEcCtD
Ceftriaxone—Rash—Calcitriol—osteoporosis	0.000294	0.00106	CcSEcCtD
Ceftriaxone—Dermatitis—Calcitriol—osteoporosis	0.000293	0.00106	CcSEcCtD
Ceftriaxone—Headache—Calcitriol—osteoporosis	0.000292	0.00106	CcSEcCtD
Ceftriaxone—Pain—Zoledronate—osteoporosis	0.000291	0.00105	CcSEcCtD
Ceftriaxone—Nausea—Alendronate—osteoporosis	0.00029	0.00105	CcSEcCtD
Ceftriaxone—Malaise—Estradiol—osteoporosis	0.00029	0.00105	CcSEcCtD
Ceftriaxone—Hypersensitivity—Risedronate—osteoporosis	0.000289	0.00105	CcSEcCtD
Ceftriaxone—Dyspepsia—Conjugated Estrogens—osteoporosis	0.000289	0.00104	CcSEcCtD
Ceftriaxone—Nausea—Raloxifene—osteoporosis	0.000285	0.00103	CcSEcCtD
Ceftriaxone—Pruritus—Ethinyl Estradiol—osteoporosis	0.000284	0.00103	CcSEcCtD
Ceftriaxone—Palpitations—Estradiol—osteoporosis	0.000284	0.00103	CcSEcCtD
Ceftriaxone—Nausea—Ibandronate—osteoporosis	0.000283	0.00102	CcSEcCtD
Ceftriaxone—Feeling abnormal—Zoledronate—osteoporosis	0.000281	0.00102	CcSEcCtD
Ceftriaxone—Pain—Conjugated Estrogens—osteoporosis	0.00028	0.00101	CcSEcCtD
Ceftriaxone—Gastrointestinal pain—Zoledronate—osteoporosis	0.000278	0.00101	CcSEcCtD
Ceftriaxone—Pruritus—Risedronate—osteoporosis	0.000277	0.001	CcSEcCtD
Ceftriaxone—Nausea—Calcitriol—osteoporosis	0.000277	0.001	CcSEcCtD
Ceftriaxone—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000275	0.000996	CcSEcCtD
Ceftriaxone—Hypersensitivity—Pamidronate—osteoporosis	0.000275	0.000994	CcSEcCtD
Ceftriaxone—Urticaria—Zoledronate—osteoporosis	0.00027	0.000979	CcSEcCtD
Ceftriaxone—Discomfort—Estradiol—osteoporosis	0.00027	0.000979	CcSEcCtD
Ceftriaxone—Body temperature increased—Zoledronate—osteoporosis	0.000269	0.000974	CcSEcCtD
Ceftriaxone—Abdominal pain—Zoledronate—osteoporosis	0.000269	0.000974	CcSEcCtD
Ceftriaxone—Diarrhoea—Risedronate—osteoporosis	0.000268	0.000971	CcSEcCtD
Ceftriaxone—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	0.000268	0.00097	CcSEcCtD
Ceftriaxone—Dizziness—Ethinyl Estradiol—osteoporosis	0.000266	0.000962	CcSEcCtD
Ceftriaxone—Pruritus—Pamidronate—osteoporosis	0.000264	0.000954	CcSEcCtD
Ceftriaxone—Anaphylactic shock—Estradiol—osteoporosis	0.000262	0.000949	CcSEcCtD
Ceftriaxone—Oedema—Estradiol—osteoporosis	0.000262	0.000949	CcSEcCtD
Ceftriaxone—Infection—Estradiol—osteoporosis	0.000261	0.000943	CcSEcCtD
Ceftriaxone—Urticaria—Conjugated Estrogens—osteoporosis	0.00026	0.000942	CcSEcCtD
Ceftriaxone—Dizziness—Risedronate—osteoporosis	0.000259	0.000938	CcSEcCtD
Ceftriaxone—Abdominal pain—Conjugated Estrogens—osteoporosis	0.000259	0.000938	CcSEcCtD
Ceftriaxone—Body temperature increased—Conjugated Estrogens—osteoporosis	0.000259	0.000938	CcSEcCtD
Ceftriaxone—Vomiting—Ethinyl Estradiol—osteoporosis	0.000256	0.000925	CcSEcCtD
Ceftriaxone—Diarrhoea—Pamidronate—osteoporosis	0.000255	0.000923	CcSEcCtD
Ceftriaxone—Hyperhidrosis—Estradiol—osteoporosis	0.000254	0.000918	CcSEcCtD
Ceftriaxone—Rash—Ethinyl Estradiol—osteoporosis	0.000254	0.000918	CcSEcCtD
Ceftriaxone—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000253	0.000917	CcSEcCtD
Ceftriaxone—Headache—Ethinyl Estradiol—osteoporosis	0.000252	0.000912	CcSEcCtD
Ceftriaxone—Hypersensitivity—Zoledronate—osteoporosis	0.000251	0.000908	CcSEcCtD
Ceftriaxone—Vomiting—Risedronate—osteoporosis	0.000249	0.000902	CcSEcCtD
Ceftriaxone—Rash—Risedronate—osteoporosis	0.000247	0.000895	CcSEcCtD
Ceftriaxone—Dermatitis—Risedronate—osteoporosis	0.000247	0.000894	CcSEcCtD
Ceftriaxone—Dizziness—Pamidronate—osteoporosis	0.000246	0.000892	CcSEcCtD
Ceftriaxone—Headache—Risedronate—osteoporosis	0.000246	0.000889	CcSEcCtD
Ceftriaxone—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.000242	0.000874	CcSEcCtD
Ceftriaxone—Pruritus—Zoledronate—osteoporosis	0.000241	0.000872	CcSEcCtD
Ceftriaxone—Nausea—Ethinyl Estradiol—osteoporosis	0.000239	0.000864	CcSEcCtD
Ceftriaxone—Vomiting—Pamidronate—osteoporosis	0.000237	0.000858	CcSEcCtD
Ceftriaxone—Paraesthesia—Estradiol—osteoporosis	0.000236	0.000853	CcSEcCtD
Ceftriaxone—Rash—Pamidronate—osteoporosis	0.000235	0.00085	CcSEcCtD
Ceftriaxone—Dermatitis—Pamidronate—osteoporosis	0.000235	0.00085	CcSEcCtD
Ceftriaxone—Headache—Pamidronate—osteoporosis	0.000233	0.000845	CcSEcCtD
Ceftriaxone—Diarrhoea—Zoledronate—osteoporosis	0.000233	0.000843	CcSEcCtD
Ceftriaxone—Nausea—Risedronate—osteoporosis	0.000233	0.000843	CcSEcCtD
Ceftriaxone—Pruritus—Conjugated Estrogens—osteoporosis	0.000232	0.000839	CcSEcCtD
Ceftriaxone—Dyspepsia—Estradiol—osteoporosis	0.000231	0.000836	CcSEcCtD
Ceftriaxone—Dizziness—Zoledronate—osteoporosis	0.000225	0.000815	CcSEcCtD
Ceftriaxone—Pain—Estradiol—osteoporosis	0.000224	0.000812	CcSEcCtD
Ceftriaxone—Diarrhoea—Conjugated Estrogens—osteoporosis	0.000224	0.000812	CcSEcCtD
Ceftriaxone—Nausea—Pamidronate—osteoporosis	0.000221	0.000801	CcSEcCtD
Ceftriaxone—Dizziness—Conjugated Estrogens—osteoporosis	0.000217	0.000784	CcSEcCtD
Ceftriaxone—Vomiting—Zoledronate—osteoporosis	0.000216	0.000783	CcSEcCtD
Ceftriaxone—Feeling abnormal—Estradiol—osteoporosis	0.000216	0.000782	CcSEcCtD
Ceftriaxone—Rash—Zoledronate—osteoporosis	0.000215	0.000777	CcSEcCtD
Ceftriaxone—Gastrointestinal pain—Estradiol—osteoporosis	0.000215	0.000776	CcSEcCtD
Ceftriaxone—Dermatitis—Zoledronate—osteoporosis	0.000214	0.000776	CcSEcCtD
Ceftriaxone—Headache—Zoledronate—osteoporosis	0.000213	0.000772	CcSEcCtD
Ceftriaxone—Vomiting—Conjugated Estrogens—osteoporosis	0.000208	0.000754	CcSEcCtD
Ceftriaxone—Urticaria—Estradiol—osteoporosis	0.000208	0.000754	CcSEcCtD
Ceftriaxone—Abdominal pain—Estradiol—osteoporosis	0.000207	0.000751	CcSEcCtD
Ceftriaxone—Body temperature increased—Estradiol—osteoporosis	0.000207	0.000751	CcSEcCtD
Ceftriaxone—Rash—Conjugated Estrogens—osteoporosis	0.000207	0.000748	CcSEcCtD
Ceftriaxone—Dermatitis—Conjugated Estrogens—osteoporosis	0.000206	0.000747	CcSEcCtD
Ceftriaxone—Headache—Conjugated Estrogens—osteoporosis	0.000205	0.000743	CcSEcCtD
Ceftriaxone—Nausea—Zoledronate—osteoporosis	0.000202	0.000732	CcSEcCtD
Ceftriaxone—Nausea—Conjugated Estrogens—osteoporosis	0.000195	0.000705	CcSEcCtD
Ceftriaxone—Hypersensitivity—Estradiol—osteoporosis	0.000193	0.0007	CcSEcCtD
Ceftriaxone—Pruritus—Estradiol—osteoporosis	0.000186	0.000672	CcSEcCtD
Ceftriaxone—Diarrhoea—Estradiol—osteoporosis	0.000179	0.00065	CcSEcCtD
Ceftriaxone—Dizziness—Estradiol—osteoporosis	0.000173	0.000628	CcSEcCtD
Ceftriaxone—Vomiting—Estradiol—osteoporosis	0.000167	0.000604	CcSEcCtD
Ceftriaxone—Rash—Estradiol—osteoporosis	0.000165	0.000599	CcSEcCtD
Ceftriaxone—Dermatitis—Estradiol—osteoporosis	0.000165	0.000598	CcSEcCtD
Ceftriaxone—Headache—Estradiol—osteoporosis	0.000164	0.000595	CcSEcCtD
Ceftriaxone—Nausea—Estradiol—osteoporosis	0.000156	0.000564	CcSEcCtD
